Why These 5 Stocks Were in the Spotlight This Week

Page 1 of 5

In this article we take a look at five stocks that were in the spotlight this week. If you want to read our detailed analysis of these stocks, go to read Why These 10 Stocks Were in the Spotlight This Week.

5. Merck & Co., Inc. (NYSE:MRK) is in the spotlight after the company announced a phase 3 trial showed Molnupiravir reduced the risk of hospitalization or death by approximately 50% compared to placebo for patients with mild or moderate COVID-19. Merck & Co., Inc. (NYSE:MRK)  plans to seeking Emergency Use Authorization in the United States for Molnupiravir as soon as possible. Of the around 873 elite funds in our database, 79 were long Merck & Co., Inc. (NYSE:MRK) at the end of Q2.

Page 1 of 5